The present invention is related to systems, devices and methods for sensing biomolecules and biochemical reactions, including but not limited to the identification and/or sequencing of DNAs, RNAs, proteins, polypeptides, oligonucleotides, polysaccharides, and their analogies, etc., either natural, synthesized, or modified. More specifically, this disclosure includes embodiments in which patterned conductive nanojunctions are created in nanogaps using DNA as a scaffold or a template.
An electronic nanodevice has great potential for biosensing in the point of care at a low cost. While a 7 nm resolution has achieved by Interference lithography,1 the traditional top-down semiconductor fabrication process used in industry is approaching its limits. On the other hand, DNA is one of the most promising and suitable materials for integrating a biological operating system to the nanoelectronics with the angstrom precision. First, DNA can be programmed to form predictable nanometer-sized structures in both two and three dimensions by self-assembly, such as 2D DNA arrays, DNA-truncated octahedrons, DNA origamis, and 3D DNA.2 Plus, sophisticated nucleic acid chemistry allows us to tune and modify DNA as well as create new DNA based materials. Thus, DNA has become a choice for the “bottom-up” construction of nanomachines.
DNA molecules could conduct electrons through overlapping 7c-orbitals of adjacent base pairs longitudinally. It has been observed that long native DNA wires are not conductive when deposited on a hard substrate,3,4 and short DNA molecules allow charge transport through them (<15 base pairs).5 In general, an AT sequence is less conductive than its GC counterpart in DNA.6 The AT base pair is considered a tunneling barrier, and the GC base pair a hopping site for the charge transfer. In aqueous solution, the conductance (G) of poly(CG)n DNA duplexes decreases with their lengths (L).8 Although a poly(CG)4 has a conductance about 100 nS (
One way to improve the conductivity of a DNA nanostructure is to add conducting materials into DNA. For electronic interconnects, the nanostructure is better to have ohmic conductivity. Metallization of DNA is an effective way to create conductive nanowire. Metals, such as platinum (Pt), gold (Au), silver (Ag), copper (Cu), palladium (Pd), and rhodium (Rd), etc., have been plated on DNA to form metalized nanowires.9 In general, these DNA templated nanowires have their diameters greater than 10 nm for good conductivity. Braun and coworkers invented a molecular lithography technology for patterning on DNA substrates,10 where an insulating gap between two gold nanowires was created on a DNA substrate.
This invention provides means and methods to increase electrical conductivity of DNA nanojunctions by coating a thin layer of metal nanoparticles or conductive polymer monomers or conjugating a conductive polymer, such as polyaniline, or a combination of both along the DNA helices attached to a nanogap.
Pre-Remarks: Although this invention uses DNA duplex as a template or substrate or scaffold to make conductive nanowires or form nanojunctions, we do not exclude the use of other materials for the same purpose, such as an RNA duplex, a polypeptide chain, a polysaccharide chain, or similar biopolymers or the combination of them, including the combination with DNA, either natural or unnatural. The principles or methods of this invention apply to any other biopolymer suitable to be used as a nanowire/nanojunction building material.
This invention provides methods to assemble a nanogap device for sensing biomolecules and biochemical reactions.
In some embodiments, the nanogap comprises two electrodes, the distance between which is in a range of 3 nm to 1000 nm, preferably 5 nm to 100 nm, and most preferably 5 nm to 30 nm. The end surfaces of the electrodes are substantially rectangular with a width in the range of 3 nm to 1 um, preferably 5 nm to 30 nm, and a height in the range of 3 nm to 100 nm, preferably 5 nm to 30 nm. The said electrodes comprise noble metals, for example, platinum (Pt), gold (Au), silver (Ag), palladium (Pd), rhodium (Rd), ruthenium (Ru), osmium (Os), iridium (Ir), or other metals, such as copper (Cu), rhenium (Re), titanium (Ti), Niobium (Nb), Tantalum (Ta), and their derivatives, such as TiN, and TaN, etc.
In some embodiments, the nanogap is formed by two electrodes which are in different planes separated by an insulation layer, see FIG. 6 (ref. U.S. 62/994,712). The thickness of the insulation layer is in the range of 2 nm to 1000 nm, preferably 5 nm to 30 nm. The insulation material is selected from, but not limited to, the group consisting of SiNx, SiOx, HfOx, Al2O3, other metal oxides, and any dielectrics used in the semiconductor industry.
In some embodiments, a nanojunction is formed by bridging the nanogap with a nanowire, and then a sensing molecule is attached at a predefined location. The said nanowire comprises a semiconductive DNA duplex segment flanked by two metalized or conductive polymer conjugated nanowire segments. A sensing molecule is attached to the DNA duplex in the middle. The attached sensing molecule and the semiconductive DNA duplex constitute a force effect transistor, referred as to “FET”. The sensing molecule changes its conformation when interacting with its receptors or substrates. This will exert a force on DNA and disturb its base stacking, resulting in fluctuation of electrical current flowing through the nanowire. The current signal, representing responses to the molecular events, is then recorded and the molecular interactions or reactions are deduced. For example, when the sensing molecule is a DNA polymerase, it can monitor the process of polymerase incorporating nucleotides into a DNA primer by recording the electric signals. When an antibody is used as the sensing molecule, an antigen can be detected utilizing this nanojunction device, or vice versa. Similarly, a receptor is used as a sensing molecule, and its ligands in a sample can be determined, or vice versa.
In one embodiment, the said DNA anchor 201 is a set of short oligonucleotides 201-a and 201-b with their sequence matching to the DNA wire 202 at different ends. The probe (anchor) oligo 201-a matches to both 202-a and a part of 202-b. In the same way, 201-b matches to both 202-c and a part of 202-d. The sequences for the probe oligos 201-a and 201-b are either the same or different. When each of them is respectively attached to those individual electrodes constituting a nanogap, they capture the DNA wire 202 to form a duplex containing nicks. After a ligating reaction, a perfect duplex forms, the middle of which comprises a semiconductive segment (209) and the rest of which can be either conductive, semiconductive or non-conductive. Due to the complementary requirement for the hybridization (capture) of 202 to 201, it requires the nanogap size to match the length of the assembled molecular wire 209.
In another embodiment, the DNA anchor 201 is hybridized to the DNA wire 202 first, forming a DNA duplex with nicks to be filled by ligation, and then attaching to the two electrodes to form the nanojunction. In order to increase the success rate of junction formation, the ends of the electrodes can be tapered as a reverse trapezoidal geometry, see illustration in FIG. 5 (ref. U.S. 62/833,870), to facilitate the landing and attaching of the DNA duplex.
In some embodiment, the DNA anchor contains a functional group configured for attachment to the electrodes. The functional group includes but not limited to (a) a thiol on a sugar ring of a nucleoside; (b) a thiol and a selenol on a nucleobase of a nucleoside; (c) an aliphatic amine on a nucleoside; (d) a catechol on a nucleoside; (e) RXH and RXXR, where R is an aliphatic or aromatic group; X is chalcogens preferring to S and Se; and (f) Base chalcogenated nucleosides. For detailed descriptions of these functional groups it refers to U.S. 62/812,736.
In some embodiments, a third electrode, the gate electrode, is introduced, see
In another embodiment, the DNA anchor 201 and the DNA wire 202 are hybridized and ligated before attaching to the electrodes or simply replaced by a pre-assembled DNA duplex with the same sequence of DNA duplex 209. The pre-assembled DNA duplex is attached to the two electrodes at the nanogap, forming a nanojunction, followed by the protein filament attachment (masking) to the middle section and the metalization of the side sections as well as the final sensing molecule attachment (see
In some embodiment, the nanowire comprises a semiconductive DNA duplex segment flanked by a metalized or conjugated conductive polymer segment at only one end. The sensing molecule is attached to pre-defined locations on the semiconductive DNA duplex segment.
In some embodiments, a pre-assembled DNA nanostructure constructed using methods disclosed in the previous provisional applications, U.S. 62/794,096 and U.S. 62/833,870, is used in place of DNA duplex 209, attaching to the electrodes directly to form nanojunction with the middle part compatible with the DNA/protein filament 205 for masking, followed by the remaining steps in
In some embodiments, the DNA wire 202 and DNA anchor 201 are complementary to the full length so that the resulting DNA duplex 209 is double stranded in its full length. While in some other embodiments, the DNA wire 202 is shorter than the nanogap size, not fully complementary DNA anchor 201, so forming a DNA duplex (209) with single-stranded oligonucleotide flanked at both ends. Either the DNA duplex 209 is all double-stranded or partial double stranded with end segments single-stranded, the remaining process for constructing the biosensing nanodevice is the same as that in
In some embodiments, the mid-section of the DNA duplex 209 carries functional groups at pre-defined nucleotides (locations), which can carry out chemical reactions to connect other entities, such as a sensing molecule, to the wire.
In some embodiments, the end segments of the DNA duplex (209) comprise phosphorothioate oligonucleotides with a structure as illustrated below:
Where n=3 to 100; R and R′ can be a variety of functional groups as listed above, but not limited to them. The phosphate/phosphorothioate (PO/PS) chimeric oligodeoxyribonucleotides can be synthesized in an automated DNA synthesizer.11 The said ligation in
In some embodiments, the said filament (205) comprises a single-stranded DNA (203) with its sequence complementary or similar (with at least about 50% sequence homology to the nucleic acid duplex segment) to the sequence of the semiconductive middle segment of the DNA wire 202 (or the mid-section of the DNA duplex 209), and a protein, such as a RecA protein (204) that can be polymerized on the single DNA strand.12 The filament can specifically bind to a homologous double-stranded DNA, and used as a mask for molecular lithography.10 In some embodiments, the said filament 205 binds to the semiconductive section of the DNA duplex (209) as a mask (210) for the metal deposition (plating) on the end segments of the DNA duplex.
In one embodiment, as an example of DNA metalization, the said metal nanowire 211 is prepared first by seeding ˜1.0 nm silver nanoparticles on the phosphorothioate via the metal thiol covalent bond, followed by washing with water to remove the excess silver nanoparticles. Then, a solution of KSCN (0.6 M) mixed with KAuCl4 (0.06 M) in a 1:1 ratio is added to the nanojunction area, followed by the addition of hydroquinone (25 mM) in the same volume with the gold plating solution. The nanojunction is incubated in the solution for 60 seconds. Then, the solution is flashed out, and the nanojunction is rinsed with water. As a result, the gold nanowire is formed at the two side segments of the DNA junction. Sequentially, the gold wire is passivated by forming a hydrophilic monolayer, for example, an oligo(ethylene glycol) monolayer on the surface to prevent the nonspecific adsorption. The filament mask is removed by protein digestion using Proteinase K to expose the semiconductive DNA segment.
In some embodiments, the seeding nanoparticles are gold in place of silver. A noble metal, either the same or different from the first electrode and/or the second electrode, is deposited on the DNA nanojunction by nanoparticle directed electroless plating. The noble metal includes but not limited to Au, Ag, Pd, Pt, Rd, etc.
In some embodiments, the plating process is carried out by an electrochemical process to specifically deposit different metals in the defined locations.
In some embodiments, the metal is deposited on the DNA duplex with well-defined metal nanoparticle seeding without employing the DNA/protein filament mask 205.
In some embodiments, the phosphorothioate groups in the DNA duplex 209 reacts with 4-Bromobutyraldehyde, resulting in aldehyde functionalized phosphorothioates, as shown below:
The aldehyde is a reducing agent for the seeding with a metal ion solution, for example, an AgNO3 solution. Other aldehydes can also be used to functionalize the phosphorothioates, which have a structure, as shown below:
In some embodiments, the metalization of the end segments of the DNA duplex 209 can be replaced by co-joining a conductive polymer into the DNA segments. The DNA anchor (201) bears the monomers of conductive polymers (CP) attached to its nucleobases, or more generally, conductive polymer monomer coupled to the single-stranded end segments of the DNA duplex 209. The structures of the monomers are shown below, including, but not limited to:
These monomers can be attached to the modified nucleosides with their nucleobases functionalized with the amine, as shown below:
Thus, these functionalized nucleosides can be incorporated into DNA oligonucleotides by an automated DNA synthesizer. An example of synthesizing terpyrrole-uridine phosphoramidite (11) is described in the EXAMPLE section. The phosphoramidite (11) is incorporated into DNA, for example, with a sequence of CXA GXT AXC GXC by an automated DNA synthesizer, where X=uridine bearing a terpyrrole monomer. The DNA is used as an anchor for attaching to the electrodes. It hybridizes with the DNA wire to form a nanojuction in the nanogap, and they are ligated together. The protein filament mask is added to the semiconductive segment. Then, the terpyrrole monomers are polymerized by electrochemical oxidation in aqueous solution at neutral pH following a prior art approach.13 After removing the mask, the nanojunction is ready to be functionalized with sensing molecules. Alternatively, the terpyrrole monomers are conjoined and polymerized along the entire DNA duplex 209 without using the protein filament mask 205.
In some embodiments, the said DNA anchor bearing the CP monomers is prepared first by synthesizing a DNA oligonucleotide bearing amino-functionalized nucleosides, and then the CP monomers are coupled to the oligonucleotide by a reaction of activated carboxylate with the amine.
In some embodiments, the said conductive polymer in the DNA nanojunction is synthesized by either chemical or enzymatic oxidation, which has been demonstrated in prior arts.14, 15
In some other embodiments, the conductive polymer is joined throughout the entire DNA duplex 209, not limited to the end segments, making the whole nanojunction comprising a conductive polymer joined to the DNA scaffold. Meanwhile, some functional groups, such as azide, thiol and its derivatives, are placed in the pre-defined locations along the DNA duplex for the attachment of the sensing molecule.
In some embodiments, conductive polymer monomers are conjugated to a DNA template or scaffold in an aqueous solution with or without a protein filament mask to form a conductive nanowire first and then the nanowire is attached to the first and the second electrodes to bridge the nanogap so to form a conductive nanojunction.
In other embodiments, first, conductive polymer monomers are deposited onto a DNA template or scaffold in an aqueous solution with or without a protein filament mask; second, the DNA template or nanowire is attached to the first and the second electrode to bridge the nanogap, and third, the conductive polymer monomers are oxidized to enhance the nanowire conductivity so a conductive nanojunction is formed.
In some embodiments, the nanowire or its underline DNA or polymer scaffold or template carries functional groups at its ends, such as azide, alkyne, or thiol and its derivatives, for the attachment to the first and the second electrodes.
In some embodiments, the DNA nanowire 209 is a duplex or a mixture of duplex with single stranded segments at the ends. In some embodiments, the DNA nanowire 209 is a triplex or a mixture of duplex, triplex, and single-stranded segments.
In some embodiment, a conductive polymer can be joined to the DNA nanowire at the end, forming a DNA-conductive polymer conjugated nanowire.
In some embodiment, the DNA scaffold underline the metalized DNA nanowire segment(s) can be replaced by any polymer that can be metalized and be joined to the DNA duplex nanowire segment, either the polymer is conductive, semiconductive or non-conductive, and either it is natural or unnatural.
In all the above, the conductive polymer is selected from, but not limited to, the group consisting of polypyrroles (PPY), polythiophenes (PT), polyanilines (PANI), poly(p-phenylene sulfide) (PPS), poly(acetylene)s (PAC), poly(p-phenylene vinylene) (PPV), poly(3,4-ethylenedioxythiophene) (PEDOT), poly(fluorene)s, polyphenylenes, polypyrenes, polyazulenes, polynaphthalenes, polycarbazoles, polyindoles, polyazepines, etc. The first three polymers, PPY, PT and PANI, are preferred due to relative easiness for synthesis.
In some embodiments, the sensing molecule is selected from, but not limited to, the group consisting of nucleic acid probes, molecular tweezers, enzymes, receptors, ligands, antigens and antibodies, either native, mutated, expressed, or synthesized, and a combination thereof.
In some embodiments, the sensing molecule is an enzyme, including but not limited to DNA polymerase, RNA polymerase, DNA helicase, DNA ligase, DNA exonuclease, reverse transcriptase, RNA primase, ribosome, sucrase, lactase, etc., either natural, mutated or synthesized.
In some embodiments, the sensing molecule is DNA polymerase, including but not limited to, any polymerase from polymerase families, A, B, C, D, X, Y, and RT. For example, those in Family A include T7 DNA polymerase and Bacillus stearothermophilus Pol I; those in Family B include T4 DNA polymerase, Phi29 DNA polymerase, and RB69; those in Family C includes the E. coli DNA Polymerase III. The RT (reverse transcriptase) family of DNA polymerases includes, for example, retrovirus reverse transcriptases and eukaryotic telomerases.
In some other embodiments, the sensing molecule is RNA polymerase, including but not limited to, viral RNA polymerases such as T7 RNA polymerase; Eukaryotic RNA polymerases such as RNA polymerase I, RNA polymerase II, RNA polymerase III, RNA polymerase IV, and RNA polymerase V; and Archaea RNA
polymerase.
In some embodiments, click reactions are used to attach sensing molecules onto nanojunctions. As an example, nucleosides containing acetylene are incorporated into the conductive DNA segments for attaching sensing molecules functionalized with azide, following methods disclosed in our PCT filing (WO 2020/150695). Their structures are shown below
In some embodiments, a plurality of nanogap devices, each having all the features of a single nanogap device with attached nanowire and sensing molecule, can be fabricated in an array format with the number of nanogap devices from 10 to 109 on a nanochip, a solid surface or in a well, preferably 103 to 107 or more preferably 104 to 106 based on the throughput requirement of the biopolymer sensing or sequencing. All of the nanogap devices in the said array is configured with one type of sensing molecule or different types of sensing molecules.
Ethyl 2-(2,5-dibromo-1H-pyrrol-yl)acetate (4) is synthesized following the route shown below:
First, ethyl 2-(1H-pyrrol-yl)acetate (3) is synthesized following the procedure in a prior art (WO 2011/094823) with modifications. To a refluxing solution of ethyl glycinate (1, 1.0 equivalent) and sodium acetate (1.7 equivalents) in an appropriate solvent, such as a co-solvent of water/acetic acid (1:2), 2,5-dimethoxytetrahydrofuran (2, 1.0 equivalent) is added. The solution is refluxed for ˜4 hours, diluted with water, neutralized with a saturated aqueous solution of NaHCO3, and extracted with CH2Cl2. The organic phase is dried over MgSO4, filtrated, and concentrated by rotary evaporation. The residue is separated by flash chromatography on a silica column and the desired compound 3 obtained in a yield of >50%. In turn, brominated pyrrole 4 is synthesized following a procedure reported in the literature.16 A solution of N-bromosuccinimide (NBS, 2.0 equiv.) in anhydrous DMF was added dropwise to a solution of compound 3 (1.0 equiv.) in anhydrous THF at 0° C. After the addition, the mixture is stirred for 30 min. The reaction is monitored by TLC until finished, stopped by the addition of water, and extracted with chloroform three times. The combined organic solution is washed with water, dried over MgSO4, filtered, and evaporated to remove the solvent. The residue is separated by flash chromatography over a silica column, furnishing the desired product with a yield of >90%.
(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrol-2-yl)boronic acid (6) is synthesized following a procedure reported in the literature.17
To a solution of 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrole (5) in anhydrous THF at ˜78° C. under argon, a solution of lithium 2,2,6,6-tetramentylpiperidide (LiTMP) is added dropwise. The solution is stirred for four hours at ˜78° C., followed by the addition of triethylborate ((EtO)3B) dropwise. The mixture is allowed to warm to room temperature for stirring an additional 12 h. The reaction mixture is quenched with saturated NH4Cl solution and stirred for 40 min. The suspension was neutralized with saturated NaHCO3 aqueous solution and stirred for 20 min. The solution is extracted three times with ether. The combined organic layer is dried over Na2SO4, and the solvent is removed by rotary evaporation. The residue is separated by flash chromatography on a silica column to obtained desired product 6.
2-(1,1″-bis((2-(trimethylsilyl)ethoxy)methyl)-1H,1′H,1″H-[2,2′:5′,2″-terpyrrol]-1′-yl)acetic acid (8) is synthesized following the route as shown below:
First, a terpyrrole ester is synthesized based on the method reported in the literature.18 The terpyrrole Pyrroleboronic acid 6 (2.3 eq.), tetrakis(triphenylphosphine)palladium(0) (10 mol %), sodium carbonate (8 eq.) and potassium chloride (3 eq.) are evacuated and flushed with argon twice. Then degassed toluene (20 mL), dibromopyrrole 4 (1 eq.), degassed ethanol and water are added. The mixture is heated for 18 h at 95° C., cooled and the solvents are removed by rotary evaporation. The residue is extracted with chloroform three times and the combined organic phase is washed with brine, dried over Na2SO4, and filtered. The solvent is removed by rotary evaporation. The residue is separated by silica gel gradient column chromatography to give the desired terpyrrole ester 7, which is converted to its corresponding carboxylic acid 8 following a mild hydrolysis procedure reported in the literature.19 The ester is dissolved in CH3CN (10 ml/g of ester) containing 2 vol % of water. Triethylamine (3 equiv.) is added, followed by the addition of LiBr (10 equiv.). The mixture is stirred vigorously at room temperature, and the product separated by silica gel gradient column chromatography.
2-(1,1″-bis((2-(trimethylsilyl)ethoxy)methyl)-1H,1 ‘H,1″H-[2,2’:5′,2″-terpyrrol]-1′-yl)-N-(3-(deoxyuridine-5-yl)prop-2-yn-1-yl)acetamide (10) is synthesized following a route as shown below:
To a solution of 8 (200 mg, 1.0 equiv.) in DMF at 0° C., HATU (2.0 equiv.) and DIEA (3.0 equiv.) are added, followed by the addition of 5-(3-aminoprop-1-yn-1-yl)-deoxyuridine 9 (1.1 equiv.) The resulting mixture is stirred at RT for one hour, and then the reaction mixture is diluted with water and extracted with ethyl acetate three times. The organic layer was dried over sodium sulfate, filtered, and concentrated by rotary evaporation. The residue is separated by flash chromatography on a silica column, furnishing the desired product 10.
5′-O-dimethoxytrityl-2-(1,1″-bis((2-(trimethylsilyl)ethoxy)methyl)-1H,1 ‘H, 1″H-[2,2’:5′,2″-terpyrrol]-1′-yl)-N-(3-(deoxyuridine-5-yl)prop-2-yn-1-yl)acetamide-3′-O-(2-cannothyl-N,N-diisopropylphosphoramidite (11) is synthesized following the route shown below:
First, to a solution of modified deoxyuridine 10 (1.18 mmol) in pyridine (3 ml) is added 4,4′-dimethoxytrityl chloride (1.30 mmol). The mixture was stirred at room temperature for one hour. TLC analysis indicated the presence of a small amount of starting material. Additional 4,4′-dimethoxytrityl chloride is added to complete the reaction. The mixture is poured into water (50 ml) and extracted with methylene chloride (3×50 ml). The combined organic phase is washed with water and dried over anhydrous Na2SO4. The product is separated by flash chromatography on a silica gel column using a mixture of methylene chloride/methanol (95:5) as eluent. Then, the tritylated product (0.57 mmol) and diisopropylammonium tetrazolide (0.57 mmol) are dissolved in methylene chloride (6 ml). To the solution is added 2-cyanoethyl N,N,N′,N′-tetraisopropylphosphorodiamidite (0.66 mmol). The solution is gently swirled, allowed to stand under nitrogen at room temperature for 1.5 h, and then diluted with ethyl acetate, washed with water, and dried over anhydrous Na2SO4. The product was separated by silica gel chromatography on a chromatotron using a mixture of ethyl acetate/triethylamine (98:2) as eluent. Compound 11 is obtained as a foamed solid.
All publications, patents, patent applications, and other documents mentioned herein are incorporated by reference in their entirety. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as those commonly understood by one of ordinary skill in the art to which this invention belongs. While the present invention has been illustrated by a description of various embodiments and while these embodiments have been described in considerable detail, it is not the intention of the applicants to restrict or in any way limit the scope of the applications. Additional advantages and modifications will readily appear to those skilled in art. The invention in its broader aspects is therefore not limited to the specific details, representative device, apparatus and method, and illustrative example shown and described. Accordingly, departures may be made from such details without departing from the spirit of the applicant's general inventive concept.
This application claims priority to U.S. Provisional Application Ser. No. 62/890,251 filed Aug. 22, 2019, the entire disclosures of which are hereby incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/047676 | 8/24/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62890251 | Aug 2019 | US |